Share：
Share this content in WeChat
X
[Chinese][PDF]71560
• Review •
Radiological research progress on the adherence and invasion of adjacent brain tissue caused by craniopharyngioma
ZHANG Lingling  CHEN Xuzhu 

Cite this article as: Zhang LL, Chen XZ. Radiological research progress on the adherence and invasion of adjacent brain tissue caused by craniopharyngioma[J]. Chin J Magn Reson Imaging, 2021, 12(12): 121-124. DOI:10.12015/issn.1674-8034.2021.12.030.


[Abstract] Some important brain tissues are around craniopharyngioma, including hypothalamus. Although craniopharyngioma is WHOⅠgrade tumor, it presents complicated effect on the adjacent brain tissues, including adherence and invasion. This behavior shows an important influence on the tumor treatment and patient prognosis. It is clinically important to identify the effect on the peritumoral brain tissues caused by the tumor in radiology. This paper is to briefly overview the radiological research status on the tumor behavior.
[Keywords] craniopharyngioma；adherence；invasion；brain tissue；magnetic resonance imaging

ZHANG Lingling   CHEN Xuzhu*  

Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China

Chen XZ, E-mail: radiology888@aliyun.com

Conflicts of interest   None.

ACKNOWLEDGMENTS National Natural Science Foundation (No.81772005); Collaborative Innovative Major Special Project Supported by Beijing Municipal Science & Technology Commission (No. Z191100006619088).
Received  2021-07-19
Accepted  2021-10-09
DOI: 10.12015/issn.1674-8034.2021.12.030
Cite this article as: Zhang LL, Chen XZ. Radiological research progress on the adherence and invasion of adjacent brain tissue caused by craniopharyngioma[J]. Chin J Magn Reson Imaging, 2021, 12(12): 121-124. DOI:10.12015/issn.1674-8034.2021.12.030.

[1]
Müller HL. Childhood craniopharyngioma: treatment strategies and outcomes[J]. Expert Rev Neurother, 2014, 14(2): 187-197. DOI: 10.1586/14737175.2014.875470.
[2]
Müller HL, Merchant TE, Warmuth-Metz M, et al. Craniopharyngioma[J]. Nat Rev Dis Primers, 2019, 5(1): 75. DOI: 10.1038/s41572-019-0125-9.
[3]
Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary[J]. Neuro Oncol, 2021, 23(8): 1231-1251. DOI: 10.1093/neuonc/noab106.
[4]
Prieto R, Pascual JM, Hofecker V, et al. Craniopharyngioma adherence: a reappraisal of the evidence[J]. Neurosurg Rev, 2020, 43(2): 453-472. DOI: 10.1007/s10143-018-1010-9.
[5]
Prieto R, Pascual JM, Rosdolsky M, et al. Preoperative assessment of craniopharyngioma adherence: Magnetic resonance imaging findings correlated with the severity of tumor attachment to the hypothalamus[J]. World Neurosurg, 2018, 110: e404-e426. DOI: 10.1016/j.wneu.2017.11.012.
[6]
Nomura H, Kurimoto M, Nagai S, et al. Multiple intracranial seeding of craniopharyngioma after repeated surgery--case report[J]. Neurol Med Chir (Tokyo), 2002, 42(6): 268-271. DOI: 10.2176/nmc.42.268.
[7]
Miller DC. Pathology of craniopharyngiomas: clinical import of pathological findings[J]. Pediatr Neurosurg, 1994, 21(Suppl 1): 11-17. DOI: 10.1159/000120855.
[8]
Tena-Suck ML, Hernández-Campos ME, Ortiz-Plata A, et al. Intracerebral injection of oil cyst content of human craniopharyngioma (oil machinery fluid) as a toxic model in the rat brain[J]. Acta Histochem, 2014, 116(3): 448-456. DOI: 10.1016/j.acthis.2013.10.002.
[9]
Pascual JM, Prieto R. Letter to the Editor: Craniopharyngiomas in the elderly: the crucial influence of tumor topography on surgical risk assessment[J]. Neuroendocrinology, 2021. DOI: 10.1159/000516172. DOI: .
[10]
Brastianos PK, Taylor-Weiner A, Manley PE, et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas[J]. Nat Genet, 2014, 46(2): 161-165. DOI: 10.1038/ng.2868.
[11]
Apps JR, Carreno G, Gonzalez-Meljem JM, et al. Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target[J]. Acta Neuropathol, 2018, 135(5): 757-777. DOI: 10.1007/s00401-018-1830-2.
[12]
Moreno-Torres B, Campos-Martín Y, Meléndez B, et al. Craniopharyngiomas: A clinicopathological and molecular study of 52 cases-experience in the Complejo Hospitalario de Toledo and Hospital Universitario 12 de Octubre (Madrid)[J]. Clin Neuropathol, 2021, 40(1): 26-35. DOI: 10.5414/NP301268.
[13]
Prieto R, Pascual JM, Rosdolsky M, et al. Craniopharyngioma adherence: a comprehensive topographical categorization and outcome-related risk stratification model based on the methodical examination of 500 tumors[J]. Neurosurg Focus, 2016, 41(6): E13. DOI: 10.3171/2016.9.FOCUS16304.
[14]
Liu Y, Qi ST, Wang CH, et al. Pathological relationship between adamantinomatous craniopharyngioma and adjacent structures based on QST classification[J]. J Neuropathol Exp Neurol, 2018, 77(11): 1017-1023. DOI: 10.1093/jnen/nly083.
[15]
Prieto R, Pascual JM. Percival S. Bailey: eminent scholar of neurosciences who revealed the workings of the hypothalamus through clinicopathological research on craniopharyngiomas[J]. J Neurosurg, 2019, 14: 1-13. DOI: 10.3171/2019.3.JNS183145. DOI: .
[16]
Pascual JM, Prieto R, Carrasco R, et al. Displacement of mammillary bodies by craniopharyngiomas involving the third ventricle: surgical-MRI correlation and use in topographical diagnosis[J]. J Neurosurg, 2013, 119(2): 381-405. DOI: 10.3171/2013.1.JNS111722.
[17]
Higashi S, Yamashita J, Fujisawa H, et al. "Moustache" appearance in craniopharyngiomas: unique magnetic resonance imaging and computed tomographic findings of perifocal edema[J]. Neurosurgery, 1990, 27(6): 993-996.
[18]
Hwang KR, Lee JY, Byun JY, et al. Infrasellar craniopharyngioma originating from the pterygopalatine fossa with invasion to the maxillary sinus[J]. Br J Oral Maxillofac Surg, 2009, 47(5): 422-424. DOI: 10.1016/j.bjoms.2008.10.003.
[19]
Pickering L, Klose M, Feldt-Rasmussen U, et al. Polysomnographic findings in craniopharyngioma patients[J]. Sleep Breath, 2017, 21(4): 975-982. DOI: 10.1007/s11325-017-1574-6.
[20]
Gil-Simoes R, Pascual JM, Casas AP, et al. Intrachiasmatic craniopharyngioma: Assessment of visual outcome with optical coherence tomography after complete surgical removal[J]. Surg Neurol Int, 2019, 10: 7. DOI: 10.4103/sni.sni_292_18.
[21]
Prieto R, Pascual JM, Barrios L. Harvey Cushing's craniopharyngioma treatment: Part 2. surgical strategies and results of his pioneering series[J]. J Neurosurg, 2018, 131(3): 964-978. DOI: 10.3171/2018.5.JNS18154.
[22]
Ebrahimi A, Honegger J, Schluesener H, et al. Osteonectin expression in surrounding stroma of craniopharyngiomas: association with recurrence rate and brain infiltration[J]. Int J Surg Pathol, 2013, 21(6): 591-598. DOI: 10.1177/1066896913486695.
[23]
Stache C, Hölsken A, Fahlbusch R, et al. Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth[J]. Neuro Oncol, 2014, 16(2): 256-264. DOI: 10.1093/neuonc/not195.
[24]
Zhu J, You C. Craniopharyngioma: Survivin expression and ultrastructure[J]. Oncol Lett, 2015,9(1): 75-80. DOI: 10.3892/ol.2014.2690.
[25]
Hankinson TC, Kleinschmidt-DeMasters BK. Adamantinomatous craniopharyngioma and xanthomatous lesions of the sella[J]. Brain Pathol, 2017, 27(3): 356-357. DOI: 10.1111/bpa.12497.
[26]
Nie J, Huang GL, Deng SZ, et al. The purine receptor P2X7R regulates the release of pro-inflammatory cytokines in human craniopharyngioma[J]. Endocr Relat Cancer, 2017, 24(6): 287-296. DOI: 10.1530/ERC-16-0338.
[27]
Yin X, Liu Z, Zhu P, et al. CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway[J]. J Cell Biochem, 2019, 120(6): 9724-9736. DOI: 10.1002/jcb.28253.
[28]
Pan J, Qi ST, Zhang JL, et al. The significance of tumor infiltrative behaviors of craniopharyngioma to hypothalamus[J]. Guangdong Med J, 2003, 24(12): 1275-1277. DOI: 10.13820/j.cnki.gdyx.2003.12.005.
[29]
Puget S, Garnett M, Wray A, et al. Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement[J]. J Neurosurg, 2007, 106(1Suppl): 3-12. DOI: 10.3171/ped.2007.106.1.3.
[30]
Van Gompel JJ, Nippoldt TB, Higgins DM, et al. Magnetic resonance imaging-graded hypothalamic compression in surgically treated adult craniopharyngiomas determining postoperative obesity[J]. Neurosurg Focus, 2010, 28(4): E3. DOI: 10.3171/2010.1.FOCUS09303.
[31]
Apps JR, Hutchinson JC, Arthurs OJ, et al. Imaging invasion: Micro-CT imaging of adamantinomatous craniopharyngioma highlights cell type specific spatial relationships of tissue invasion[J]. Acta Neuropathol Commun, 2016, 4(1): 57. DOI: 10.1186/s40478-016-0321-8.
[32]
Hayashi Y, Sasagawa Y, Oishi M, et al. Radiological and endocrinological evaluations with grading of hypothalamic perifocal edema caused by craniopharyngiomas[J]. Pituitary, 2019, 22(2): 146-155. DOI: 10.1007/s11102-019-00945-z.
[33]
Zhang LL, Zhang Y, Chen HY, et al. Routine MRI study of craniopharyngioma with brain invasion[J]. Chin J Magn Reson Imaging, 2020, 11(7): 522-525. DOI: 10.12015/issn.1674-8034.2020.07.009.
[34]
Pascual JM, Prieto R, Castro-Dufourny I, et al. Craniopharyngiomas primarily involving the hypothalamus: A model of neurosurgical lesions to elucidate the neurobiological basis of psychiatric disorders[J]. World Neurosurg, 2018, 120: e1245-e1278. DOI: 10.1016/j.wneu.2018.09.053.
[35]
Daubenbüchel AM, Özyurt J, Boekhoff S, et al. Eating behaviour and oxytocin in patients with childhood-onset craniopharyngioma and different grades of hypothalamic involvement[J]. Pediatr Obes, 2019, 14(9): e12527. DOI: 10.1111/ijpo.12527.
[36]
Fjalldal S, Follin C, Svärd D, et al. Microstructural white matter alterations and hippocampal volumes are associated with cognitive deficits in craniopharyngioma[J]. Eur J Endocrinol, 2018, 178(6): 577-587. DOI: 10.1530/EJE-18-0081.
[37]
Ma G, Kang J, Qiao N, et al. Non-invasive radiomics approach predict invasiveness of adamantinomatous craniopharyngioma before surgery[J]. Front Oncol, 2021, 10: 599888. DOI: 10.3389/fonc.2020.599888.
[38]
Conti A, Pontoriero A, Ghetti I, et al. Benefits of image-guided stereotactic hypofractionated radiation therapy as adjuvant treatment of craniopharyngiomas. A review[J]. Childs Nerv Syst, 2019, 35(1): 53-61. DOI: 10.1007/s00381-018-3954-z.
[39]
Müller HL. Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity[J]. Curr Opin Endocrinol Diabetes Obes, 2016, 23(1): 81-89. DOI: 10.1097/MED.0000000000000214.
[40]
Huang ZS, Xiao X, Li XD, et al. Machine learning-based multiparametric magnetic resonance imaging radiomic model for discrimination of pathological subtypes of craniopharyngioma[J]. J Magn Reson Imaging, 2021. DOI: . DOI: 10.1002/jmri.27761.
[41]
Zhang Y, Shang L, Chen C, et al. Machine-learning classifiers in discrimination of lesions located in the anterior skull base[J]. Front Oncol, 2020, 10: 752. DOI: 10.3389/fonc.2020.00752.

PREV Advances in functional magnetic resonance imaging for renal function assessment
NEXT Characteristic analysis of DWI and HRMR-VWI in patients with symptomatic middle cerebral atherosclerotic stenosis: comparison between the young group and middle-aged and elderly group
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn